Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)

NCT07298564 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome (PCOS)

Interventions

DIETARY_SUPPLEMENT: Magnesium 500 mg
DIETARY_SUPPLEMENT: Levocarnitine 1000 mg
DIETARY_SUPPLEMENT: Placebo
DIETARY_SUPPLEMENT: Magnesium 500 mg
DIETARY_SUPPLEMENT: Placebo Levocarnitine

Sponsor

Behnood Abbasi